Re-Cap & Update on GT Biopharma (OXIS)
For the last week, we’ve been covering a company that has seen a huge bump in attention and trading momentum. GT Biopharma (OXIS) could be at a major tipping point. This not only comes after the recent surge in trading but also following the company’s most recent announcements. These include the addition of new patients to the company’s Phase 2 FDA trials as well as the previously announced agreement to acquire Georgetown Translational Pharmaceuticals Inc.
This morning (OXIS) announced that it will be holding a conference call, hosted by www.biotechstocks.com, to discuss the upcoming merger of Georgetown Translation Pharmaceuticals, Inc. and advancements made with the targeted immunotherapies currently in FDA clinical trials.
Senator Cory Booker Tries to Legalize Marijuana Nationally
Earlier this week, Sen. Cory Booker (D-NJ) introduced legislation that would begin to end the unfair prohibition of marijuana throughout the federal government. The bill would also serve to repair the damage done to the country via prohibition.
CNRP Mining, Inc. (CRPGF) Shows Why The Benefits of CBD are too Hard to Ignore
Cannabis is a miracle plant that has the potential to treat countless devastating conditions. Epilepsy, Multiple Sclerosis, Anxiety, Cancer Treatment & the list goes on and on. Cannabis can & has improved daily life for 10’s of millions of people across the globe and we need to recognize it for what it is, a MEDICINE. This Street is starting to take notice and CNRP Mining, Inc. (CRPGF) is the company they’re starting to look at.